Aryl fructose-1,6-bisphosphatase inhibitors
US7371739B2 · kind B2 · utility
4Cited by
21References
79Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2005 |
| Grant date | May 13, 2008 |
| Priority date | — |
| Expiry date | Jul 26, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65586
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel FBPase inhibitors of the formula Iare useful in the treatment of diabetes and other conditions associated with elevated blood glucose.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.